Your browser doesn't support javascript.
loading
Efficacy and safety of oral semaglutide in Japanese patients with type 2 diabetes: A post hoc subgroup analysis of the PIONEER 1, 3, 4 and 8 trials.
Araki, Eiichi; Terauchi, Yasuo; Watada, Hirotaka; Deenadayalan, Srikanth; Christiansen, Erik; Horio, Hiroshi; Kadowaki, Takashi.
  • Araki E; Department of Metabolic Medicine, Faculty of Life Sciences, Kumamoto University, Kumamoto, Japan.
  • Terauchi Y; Yokohama City University, Yokohama, Japan.
  • Watada H; Department of Metabolism and Endocrinology, Juntendo University Graduate School of Medicine, Tokyo, Japan.
  • Deenadayalan S; Novo Nordisk A/S, Søborg, Denmark.
  • Christiansen E; Novo Nordisk A/S, Søborg, Denmark.
  • Horio H; Novo Nordisk Pharma Ltd, Tokyo, Japan.
  • Kadowaki T; Toranomon Hospital, Tokyo, Japan.
Diabetes Obes Metab ; 23(12): 2785-2794, 2021 12.
Article en En | MEDLINE | ID: mdl-34472698
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Diabetes Mellitus Tipo 2 Tipo de estudio: Clinical_trials Límite: Humans País como asunto: Asia Idioma: En Año: 2021 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Diabetes Mellitus Tipo 2 Tipo de estudio: Clinical_trials Límite: Humans País como asunto: Asia Idioma: En Año: 2021 Tipo del documento: Article